Results 111 to 120 of about 1,341,364 (309)
International Journal of Cancer, Volume 157, Issue 5, Page 964-979, 1 September 2025.What's new? Currently, no published data on homologous recombination deficiency (HRD) testing in the setting of molecular tumor boards exist. This study in a cohort of 237 patients encompassing 24 different tumor entities assessed by a molecular tumor board shows that inactivating alterations of BRCA1/2 are not always associated with an elevated ...
Christoph Schubart +26 more
wiley +1 more source
Cervical, vaginal and vulvar intraepithelial neoplasms [PDF]
, 2011 nem
Mitrović-Jovanović Ana +5 more
core +1 more source
Late Bowel Symptoms in Long‐Term Survivors of Prostate Cancer Following Radiotherapy
The Prostate, Volume 85, Issue 13, Page 1181-1188, September 15, 2025.ABSTRACT Background Despite advances in radiotherapy planning, some long‐term prostate cancer survivors experience persistent symptoms. Although overall quality of life appears comparable between patients treated with definitive and salvage radiotherapy and aligns with normative data, prostate‐specific deficits—particularly bowel symptoms—may persist ...
Isabella Gruber +2 more
wiley +1 more source
Descriptive epidemiology of vulvar and vaginal cancers in Vaud, Switzerland, 1974-1994 [PDF]
, 2017 Background: To analyse trends in incidence, survival and risk of second neoplasms following vaginal and vulvar cancers using data collected by the Swiss Cancer Registry of Vaud over the 21-year period 1974-1994.
La Vecchia, C. +2 more
core
Renal clearance of fluorescent agents can compromise image‐guided surgery along the urinary tract
BJU International, Volume 136, Issue 3, Page 515-522, September 2025.Objectives To study the effect of renally cleared fluorescent agents on image‐guided surgery along the urinary tract by using the renally cleared, non‐tumour‐specific, fluorescent dye fluorescein. Subjects and Methods Sixteen patients who underwent robot‐assisted radical prostatectomy (RARP) with lymph node dissection received an intradermal injection ...
Anne‐Claire Berrens +9 more
wiley +1 more source
Cancer, Volume 131, Issue 16, 15 August 2025.Abstract Background In Botswana, a multidisciplinary team (MDT) clinic was established in 2015 to streamline care for all patients with gynecological malignancies including cervical cancer, Botswana’s leading cause of cancer mortality. Methods Patients presenting at the MDT clinic in Gaborone, Botswana, were prospectively enrolled.
Emily MacDuffie +16 more
wiley +1 more source
The Role of Photodynamic Therapy in the Treatment of Vulvar Intraepithelial Neoplasia
Biomedicines, 2018 Background: vulvar intraepithelial neoplasia is a non-invasive precursor lesion found in 50–70% of patients affected by vulvar squamous cell carcinoma. In the past, radical surgery was the standard treatment for vulvar intraepithelial neoplasia, however,
Giulio Tosti +6 more
doaj +1 more source
New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancer [PDF]
, 2012 A summit on cellular therapy for cancer discussed and presented advances related to the use of adoptive cellular therapy for melanoma and other cancers. The summit revealed that this field is advancing rapidly.
A Lundqvist +48 more
core +4 more sources
HPV-associated vulvar carcinoma with sebaceous differentiation. [PDF]
Gynecol Oncol Rep, 2023 Kuan I +4 more
europepmc +1 more source
Gynecologic Oncology ReportsThere is limited data regarding the use of immunotherapy for patients with vulvar squamous cell carcinoma and coexisting autoimmune disease. Cemiplimab is a PD-1 inhibitor approved for use in patients with locally advanced and metastatic cutaneous ...
Elizabeth G. Thayer +6 more
doaj